Controlled-release of apatinib for targeted inhibition of osteosarcoma by supramolecular nanovalve-modified mesoporous silica

Targeted delivery of antitumor drugs has been recognized as a promising therapeutic modality to improve treatment efficacy, reduce the toxic side effects and inhibit tumor recurrence. In this study, based on the high biocompatibility, large specific surface area, and easy surface modification of sma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinglong, Li, Gongke, Li, Ke, Shi, Yu, Lin, Wenzheng, Pan, Chun, Li, Dandan, Chen, Hao, Du, Jianwei, Wang, Huihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978000/
https://www.ncbi.nlm.nih.gov/pubmed/36873361
http://dx.doi.org/10.3389/fbioe.2023.1135655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978000/
https://www.ncbi.nlm.nih.gov/pubmed/36873361
http://dx.doi.org/10.3389/fbioe.2023.1135655

Ejemplares similares